Dow Down 0.62% Nasdaq Down 1.14%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
12.99 0.49(3.64%) Sep 22, 4:00PM EDT
Prev Close:13.48
Open:13.50
Bid:N/A
Ask:13.80 x 500
1y Target Est:23.42
Beta:4.16
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:12.81 - 13.64
52wk Range:8.61 - 18.48
Volume:2,620,655
Avg Vol (3m):2,366,940
Market Cap:1.19B
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXDown 3.64%1.19B
BAX39.04B
SHPG50.10B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):123.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.89
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.51

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback